Key statistics
On Thursday, Hydreight Technologies Inc (NURS:CVE) closed at 0.540, -20.59% below its 52-week high of 0.68, set on Nov 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.540 |
---|---|
High | 0.55 |
Low | 0.50 |
Bid | 0.51 |
Offer | 0.55 |
Previous close | 0.51 |
Average volume | 76.07k |
---|---|
Shares outstanding | 40.32m |
Free float | 14.17m |
P/E (TTM) | -- |
Market cap | 20.56m CAD |
EPS (TTM) | -0.0439 CAD |
Data delayed at least 15 minutes, as of Nov 14 2024 19:29 GMT.
More ▼
- Hydreight Technologies Inc. Ranks 9th in Deloitte’s Technology Fast 50 Program Winners for 2024
- VSDHOne Expands to Offer Asynchronous Telehealth Treatments Including Skincare, Hair Loss, and Sexual Health
- Hydreight Provides Corporate Update Reflecting Significant Growth
- Hydreight Announces Normal Course Issuer Bid
- Hydreight Reports Record Topline¹ Revenue of $5.59M in Q2-2024 (YOY Increase of 27%) and positive Adjusted EBIDTA¹
- Hydreight Expands Its “At-Home Blood Testing” Solution with More Tests to All 50 States
- Hydreight Provides Corporate Update Reflecting Significant Revenue Growth and Strong Organic Operational Growth
- Hydreight Adds The Third National Wellness Medspa Franchise for White Label Solution
- Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That Helps Companies Launch A D2C Healthcare Brand In All 50 States
- Hydreight Reports Record Topline(1) Revenue of $4.87M in Q1-2024 (YOY Increase of 33%)
More ▼